Workflow
ESGold Announces Brokered LIFE Offering for Gross Proceeds of up to C$5 Million
aTyr PharmaaTyr Pharma(US:LIFE) Newsfile·2025-09-05 11:30

Core Viewpoint - ESGold Corp. has announced a brokered private placement offering to raise gross proceeds of up to C$5 million through the sale of units priced at C$0.75 each [1][2]. Group 1: Offering Details - The offering consists of up to 6,666,667 units, each unit comprising one common share and one warrant [1][2]. - Each warrant allows the holder to purchase one common share at a price of C$1.10 within 36 months following the closing date [2]. - The company has granted the agent an option to sell an additional 1,000,000 units for up to C$750,000 in gross proceeds [3]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized for advancing the Montauban Project in Québec and for general working capital and corporate purposes [4]. Group 3: Regulatory Compliance - The offering will comply with applicable regulatory requirements and will be available to purchasers in specific Canadian provinces, the United States, and offshore jurisdictions [5]. - The securities issued will be freely tradeable in Canada if sold to Canadian residents, without a hold period [5]. Group 4: Closing and Conditions - The offering is scheduled to close on September 18, 2025, subject to necessary regulatory approvals, including that of the Canadian Securities Exchange [7]. Group 5: Company Overview - ESGold Corp. is a pre-production resource company focused on clean mining and exploration, with its flagship Montauban property located 80 kilometers west of Quebec City [10].